Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00075868
Status:
COMPLETED
Last Update Posted:
2015-11-17
First Post:
2004-01-09
Brief Title:
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Sponsor:
Radiation Therapy Oncology Group
Organization:
Radiation Therapy Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Radiation Enteritis |
| Anal Cancer |
| Colorectal Cancer |
| DrugAgent Toxicity by TissueOrgan |
Keywords:
| Name | View |
|---|---|
| radiation enteritis | View |
| drugagent toxicity by tissueorgan | View |
| stage I rectal cancer | View |
| stage II rectal cancer | View |
| stage III rectal cancer | View |
| stage IIIA anal cancer | View |
| stage IIIB anal cancer | View |
| recurrent anal cancer | View |
| stage I anal cancer | View |
| stage II anal cancer | View |
| recurrent rectal cancer | View |